Germany: Zentiva secures approximately 85.27% of Apontis Pharma voting rights in public purchase offer
Czech-based Zentiva Pharma has secured approximately 83.57% of the share capital and approximately 85.27% of voting rights in the context of its voluntary public...
Germany: VidaCura takes over two retirement homes from Bungert family
VidaCura, a group of independent and managed operators of inpatient care facilities and senior residences in Germany, has taken over two inpatient care facilities...
Switzerland: Adragos Pharma acquires Swiss sterile fill-finish firm
Adragos Pharma, a Germany-based global pharmaceutical CDMO, has acquired Baccinex, a Swiss-based expert in aseptic fill-finish manufacturing. The acquisition enhances Adragos’ sterile manufacturing capabilities...
Denmark: Adcendo completes oversubscribed US$135m Series B financing
Adcendo, a biotech company focused on the development of ADCs for the treatment of cancers with a high unmet medical need, has closed an...
Italy: 21 Invest announces first close of healthcare fund
21 Invest, an investor in mid-market companies based in Europe, has launched the 21 Invest Healthcare fund, the group’s first investment vehicle dedicated to the healthcare...
Germany: Healthcare Activos continues European expansion with entry into German market
Healthcare Activos has announced the acquisition of four new assets in Germany and Belgium that strengthen its position in Europe. The acquisition in the...
Italy: HIG Capital announces sale of Deenova
Alternative investment firm HIG Capital is selling Deenova, an Italy-based company operating in the field of traceability of drugs and medical devices in European...
Germany: Gimv sells majority stake in rehaneo to Fremman Capital
Pan-European mid-market investment firm, Fremman Capital, has taken over the majority stake in rehaneo, a leading provider of outpatient rehabilitation, aftercare, prevention, and occupational...
Switzerland: Partners Group expands growth equity strategy
Partners Group, one of the largest firms in the global private markets industry, has announced plans to expand its growth equity strategy. The expanded...
Italy: LB Research joins the 1MED Group
Switzerland-based CRO 1MED, an Apposite Capital portfolio company, has acquired LB Research, an Italy-based full-service CRO.
The addition of LB will enhance 1MED’s clinical service...
Advertisement
